Consensus Estimates
| Metric | Q4 FY2025 Estimate | Q4 FY2024 Actual (implied) | YoY Change |
|---|---|---|---|
| Revenue | ~$537.5M | ~$551.6M | -2.7% |
| EPS (GAAP) | ~$0.30 | — | — |
| Adjusted EBITDA | Watching for debt coverage | — | Critical for dividend |
Analyst consensus: Sell (4 analysts). Average price target: $4.38 vs. current price of $5.18.
Key Metrics to Watch
1. Revenue Decline Rate — Stabilizing or Accelerating?
FY2024 revenue declined 6.3% and FY2023 declined 4.7%. The FY2025 estimate implies a 4.6% decline — a modest improvement in the rate of deterioration. If Q4 shows the decline stabilizing (i.e., less than -4% YoY), it would be the first credible sign that portfolio rationalization and divestiture strategy is working.
2. Dividend Sustainability
B&G currently pays a dividend yielding approximately 15% — extraordinarily high and widely viewed as unsustainable given the declining revenue base and heavy debt load. Management commentary on the dividend is critical: any reduction would trigger significant selling pressure among the yield-seeking retail investors who have held the stock, but maintaining it while burning FCF is also untenable. Tonight could bring a formal dividend cut announcement.
3. EBITDA and Debt Service Coverage
With $2B+ in long-term debt, B&G’s ability to service its obligations depends on EBITDA holding up. Investors will parse the adjusted EBITDA figure against interest expense to assess coverage ratios. Deteriorating coverage (below 2x) would raise refinancing risk flags. Any update on debt reduction progress from recent asset divestitures would also be closely watched.
4. Volume vs. Price Mix
Are revenue declines being driven by pricing concessions (bad) or volume loss to private label (structural)? Management has historically relied on pricing to offset volume pressure — if pricing is also now rolling over, the revenue trajectory could worsen beyond consensus expectations.
5. Portfolio Rationalization Update
B&G has been divesting underperforming brands to pay down debt — the Crisco sale to Smucker’s being the most notable example. Any announcement of additional divestitures, the proceeds, and how they’re being applied to the balance sheet would be the most actionable positive catalyst B&G can offer at this juncture.
Scenario Analysis
Bull case: Revenue decline stabilizes, EBITDA holds steady, debt service is covered, and management announces another asset sale that materially reduces leverage. The dividend is maintained, relieving the most acute investor fear. The stock, at $5.18, pops modestly toward $6.
Base case: Revenue declines in line with estimates (-2 to -3%), management maintains the dividend but signals it’s under review, and EBITDA is roughly stable. The stock stays range-bound between $4.50–$5.50 — uninspiring but not catastrophic.
Bear case: Revenue declines accelerate, EBITDA erodes, and management announces a dividend cut. Debt service concerns resurface. Given the already-Sell consensus, a meaningful negative surprise here could push the stock toward or below the $3.50 low end of the analyst price target range.
Context: Recent Trends
B&G Foods is the cautionary tale of the post-pandemic leveraged-acquisition hangover in consumer staples. The company spent years buying legacy brands — often paying premium multiples — on the thesis that branded staples offered pricing power and stable cash flows. That thesis worked until it didn’t: inflation-era consumers discovered private label, category managers cut shelf space for mid-tier brands, and B&G’s portfolio of largely unrelated food brands proved difficult to manage efficiently at scale.
The debt burden is the most acute problem. With $2B+ in obligations and declining EBITDA, the balance sheet is stretched. Asset sales are the primary deleveraging tool, but selling assets in a challenged branded food market isn’t easy — buyers want the assets cheap, and B&G needs premium valuations to make the math work. The dividend, while attractive on paper, has become a source of investor anxiety rather than comfort.
Tonight’s earnings won’t resolve the strategic dilemma. But they will provide the clearest recent data point on whether management’s portfolio rationalization strategy is buying time or simply delaying an inevitable restructuring. A Sell consensus and a price target below the current stock price says the Street has already made its judgment.
Earnings call begins after market close. Follow AlphaStreet for live transcript coverage and post-earnings results analysis.
Source: StockAnalysis, AlphaStreet Earnings Calendar. Estimates as of March 3, 2026. Consensus figures are approximate and subject to revision.